Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer, CISTO Study

This study compares therapy within the bladder (intravesical therapy) and surgery as treatment options for patients with bladder cancer. Bladder cancer is the fifth most common cancer in the United States, but not enough research is available to help patients decide between the two most common treatments: medical therapies or bladder removal. The purpose of this study is to compare how the two treatments affect patient clinical outcomes and patient and caregiver experiences. This study may help researchers improve the decision-making process about bladder cancer treatments for patients and their caregivers.

Disease Sites:

Bladder

Staging:

N/A

Age Group:

Adults

Therapies:

Not Available

Drugs:

Not Available

Principal Investigator(s):

Scarpato, Kristen

Scope:

National

Participating Institutions:

Vanderbilt University

Open Date:

01-12-2020

Trial Type:

Health Services Research

Protocol ID:

VICCURO19105

National Clinical Trial ID:

NCT03933826

View Internal Documents

Eligibility

Ages Eligible for Study:

18 Years

Genders Eligible for Study:

BOTH

Accepts Healthy Volunteers?:

YES

Clinical Trials Search at Vanderbilt-Ingram Cancer Center

Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer, CISTO Study

Eligibility